Why MAIA Biotechnology, Inc.’s (MAIA) Stock Is Down 5.25%
As of Thursday, November 19, MAIA Biotechnology, Inc.’s MAIA share price has dipped by 5.25%, which has investors questioning if this is right time to buy.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Jenna Brashear
Rosalio Madrigal
Michael Rose
Michael Rose
| Share Statistics | MAIA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $70.4 | $212.8 | 20% |
|
| Shares Out (Mil) | 60.9 | 55.2 | 52% |
|
| Institutional Ownership | 68.8% | 93.3% | 42% |
|
| Float (Mil) | 56.1 | 40.8 | 49% |
|
| Beta | 0.30 | 1.03 | 17% |
|
| Avg Daily Volume (000s) | 744 | 559 | 64% |
|
| Price Change (52-week) |
12.9% | 40.3% | 64% |
|
| Growth | MAIA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (27.7%) | (10.5%) | 15% |
|
| EPS (5yr) | 14.2% | 15.4% | 55 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 34.0% | (15.7%) | 88% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 1 | |
| Current EPS | ($0.135) | ($0.540) | ($0.480) | |
| Month Ago EPS | ($0.140) | ($0.540) | $1.110 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | ($0.140) | ($0.540) | $1.110 | |
| Year/Year Chg | 14.4% | (22.5%) | na | |
| Financials | MAIA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $40 | na |
|
| Net Income (TTM) (Mil) | ($25) | ($44) | 22% |
|
| EPS (TTM) | ($0.492) | ($1.400) | 27% |
|
| Operating Cash Flow (TTM) (Mil) | ($25) | ($34) | 14% |
|
| Net Cash Flow (TTM) (Mil) | na | $-0 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $41 | $142 | 16% |
|
| Valuation | MAIA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.75 | 1.97 | 81% |
|
| P/E | na | 16.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.8 | na |
|
| Ratios | MAIA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.6% | na |
|
| Net Margin | na | (50.8%) | na |
|
| ROA | (148.3%) | (47.4%) | 3% |
|
| ROE | (341.5%) | (51.4%) | 2% |
|
| Liabilities to Assets | 33.6% | 29.6% | 25% |
|
| F-Score | 2 | 3 | 7% |
|
Passing Stock Screens
As of 11/19/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | -3.3% |
| +/- S&P 500: | -10.7 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors